Small Molecules
15 January 2014
FDA Advisory Panel Recommends Approval of Chelsea Therapeutics’ NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOH14 January 2014
Wilson Therapeutics Announces Successful Filing of U.S. IND to Advance WTX101 Development Program for Wilson Disease14 January 2014
D-Pharm Announces Recruitment of the First Patient Into Its Phase 2 Clinical Trial With DP-b99 in Acute High-Risk Pancreatitis14 January 2014
MEI Pharma Initiates Phase II Clinical Trial Of Pracinostat In Refractory Myelodysplastic Syndrome14 January 2014
MediciNova Announces Positive Results in NASH Mouse Model With MN-001 and Prepares to Initiate Phase 2 Trial in the U.S.14 January 2014
Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation13 January 2014
ZS Pharma Announces Positive Results From the Extended Treatment Phase of Its Phase 3 Trial of ZS-9 in Patients With Hyperkalemia13 January 2014
Cynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-13027713 January 2014
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma13 January 2014
Dezima Pharma Completes Patient Enrolment for TULIP Phase 2b Study with CETP Inhibitor TA-899513 January 2014
U.S. FDA Approves Farxiga™ (Dapagliflozin) Tablets for the Treatment of Adult Patients with Type 2 Diabetes10 January 2014
Synta Announces Launch of GANNET53, a Randomized, pan-European Study of Ganetespib in p53 Mutant, Metastatic Ovarian Cancer10 January 2014
ADAMAS PHARMACEUTICALS EARNS $40 MILLION IN MILESTONE PAYMENTS FROM FOREST LABORATORIES FOR MDX-87049 January 2014
BerGenBio Presents Data at AACR-ISLAC Conference on the Molecular Origins of Lung Cancer9 January 2014
Aerie Pharmaceuticals Reports Positive Results for Lead Candidate AR-13324 in Normotensive IndividualsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports